An aplastic crisis associated with parvovirus infection occurred in a patient suffering from hereditary erythrocytic multinuclearity associated with a positive acidified (Hams) test (HEMPAS). This case emphasises that any patient who has a shortened red cell survival is susceptible to an aplastic crisis induced by parvovirus.
Intravenous regional anesthesia (IVRA) is useful during short surgeries, but is not effective against pain due to tourniquet applications or postoperative pain. Several attempts have been made to identify a useful technique that can be coadministered with IVRA to reduce postoperative and tourniquet-related pain. The present study represents one such attempt, in which the authors combined IVRA with low-level laser therapy and assessed the effects on pain following surgical fixation of distal radial fractures.
Despite the whole world’s effort for controlling an ongoing global outbreak caused by new corona virus; it is still a major public health issue. Any hospitalized patient or outpatient in burn departments should be considered as a potential infectious source of COVID-19, which may cause an overwhelming of disease. However, there are no previous experiences about COVID-19 in burn patients all over the world, and here we reported two burn cases at Amir-al-Momenin Burn Hospital Affiliated to Shiraz University of Medical Sciences, Shiraz, Iran with skin manifestations, which were detected as a rarely COVID-19 symptom. A 13-year-old girl [total body surface area (TBSA): 18%] and a 37-year-old woman (TBSA: 30%) who had burn injuries by gas explosion and car accident, respectively were enrolled. After admission, some vesicular injuries were visible in burn area. To confirm, skin biopsy specimens were either sent for histopathology examination or for real time polymerase chain reaction (PCR) as follow: Herpes Simplex Virus (HSV), chicken pox, and potassium hydroxide (KOH) for fungal infections. All test results were negative. Although they had no symptoms of COVID-19, two swabs from nasopharyngeal and oropharyngeal samplings were taken, the result was negative either. Specimens were obtained from vesicular lesions for qRT-PCR assay of COVID-19. According to the molecular results for vesicular samples, all the results were positive for COVID-19. Unlike all other COVID-19 patients who have respiratory symptoms, SARS-COV-2 appeared by cutaneous vesicular and blisters in two burn cases.
Background: Extra corporeal membrane oxygenation (ECMO) has been considered as a crucial modality for the management of acute respiratory distress syndrome (ARDS). Since ECMO is considered to be an invasive modality and may be associated with some complications, there are strict indications for its use. Here we report successful treatment of a case of severe ARDS with Veno-Venous ECMO. Case presentation: A 30 years o l d male was admitted to Nemazee Hospital i n Shiraz with decreased level of consciousness due to cerebral hemorrhage following fibrinolytic therapy for myocardial infarction with ST elevation (STEMI). After diagnosis of moderate to severe ARDS, VV-ECMO was used for the management of ARDS. In this case, 5 days after starting ECMO, PaCO2 improved and O2Sat was maintained at 97-98%, so weaning was considered. Ventilator mode was BIPAP with FiO2 40% and sweep flow was 1.7L/min. We clamped the sweep flow and observed whether the patient was able to maintain O2 Sat at 97% with ventilation alone. Then, we decided to disconnect the patient from ECMO. The patient remained stable afterwards. Conclusion: Our case was intubated and was on MV from 10 days prior to ECMO administration.Moreover, our patient had simultaneous multi-organ involvement (nephrotic syndrome and sepsis) which decreased the benefits of ECMO. Despite all these problems, ECMO was started and patient was discharged from ICU with an acceptable health condition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.